Probiotic supplementation with Lactobacillus casei (Actimel) induces a Th1 response in an animal model of antiphospholipid syndrome

Annals of the New York Academy of Sciences

Volumn 1110, Issue , 2007, Pages 661-669

  Amital, Howard ^a,b,c   Gilburd, B ^b,c   Shoenfeld, Yehuda ^b,c  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Antiphospholipid syndrome; Cytokines; Nutrition; Probiotics; T cells

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; PROBIOTIC AGENT; THYMIDINE; YOGHURT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPHOSPHOLIPID SYNDROME; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOT PAD; IMMUNE SYSTEM; IMMUNIZATION; LACTOBACILLUS CASEI; LYMPH NODE; LYMPHOCYTE; MOUSE; NONHUMAN; STATISTICAL SIGNIFICANCE; SUPPRESSOR CELL; T LYMPHOCYTE; TH1 CELL;

ANIMALIA; LACTOBACILLUS CASEI; MURINAE; MUS;

EID: 35748954356     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1423.069     Document Type: Conference Paper

References (22)

1. CHERMESH, I. & R. ELIAKIM. 2006. Probiotics and the gastrointestinal tract: where are we in 2005? World J. Gastroenterol. 12: 853-857.
2. MARTEAU, P.R. 2002. Probiotics in clinical conditions. Clin. Rev. Allergy Immunol. 22: 255-273.
3. VENTURI, A., P. GIONCHETTI, F. RIZZELLO, et al. 1999. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment. Pharmacol. Ther. 13: 1103-1108.
4. KATO, K., S. MIZUNO, Y. UMESAKI, et al. 2004. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment. Pharmacol. Ther. 20: 1133-1141.
5. MALCHOW, H. A. 1997 Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J. Clin. Gastroenterol. 25: 653-658.
6. PRANTERA, C., M.L. SCRIBANO, G. FALASCO, et al. 2002. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 51: 405-409.
7. ASHERSON, R. A., M.A. KHAMASHTA & J. ORDI-ROS. 1989. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 68: 366-374.
8. BLANK, M., J. GEORGE & V. BARAK. 1998. Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome. J. Immunol. 161: 5303-5312.
9. BLANK, M., Y. SHOENFELD & S. CABILLY. 1999. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc. Natl. Acad. Sci. U S A 96: 5164-5168.
10. DORON, S. & S.L. GORBACH. 2006. Probiotics: their role in the treatment and prevention of disease. Expert. Rev. Anti. Infect. Ther. 4: 261-275.
11. AMITAL, H., B. GILBURD & Y. SHOENFELD. 2003. Intelligent nutrition: health-promoting mechanisms of probiotics1. Isr. Med. Assoc. J. 5: 812-813.
12. GIONCHETTI, P., F. RIZZELLO & U. HELWIG. 2003. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124: 1202-1209.
13. SOLIS-PEREYRA, B., N. AATTOURI & D. LEMONNIER. 1997. Role of food in the stimulation of cytokine production. Am. J. Clin. Nutr. 66: 521S-525S.
14. MALIN, M., P. VERRONEN, H. MYKKANEN, et al. 1996. Increased bacterial urease activity in faeces in juvenile chronic arthritis: evidence of altered intestinal microflora? Br. J Rheumatol. 35: 689-694.
15. BAHARAV, E., F. MOR, M. HALPERN, et al. 2004. Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. J Nutr. 134: 1964-1969.
16. BORCHERS, A. T., C.L. KEEN & M.E. GERSHWIN. 2002. The influence of yogurt/ Lactobacillus on the innate and acquired immune response. Clin. Rev. Allergy Immunol. 22: 207-230.
17. KANO, H., T. KANEKO, S. KAMINOGAWA. 2002. Oral intake of Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1 prevents collagen-induced arthritis in mice. J. Food Prot. 65: 153-160.
18. HATAKKA, K., J. MARTIO, M. KORPELA, et al. 2003. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis - a pilot study. Scand. J. Rheumatol. 32: 211-215.
19. CALCINARO, F., S. DIONISI & M. MARINARO. 2005. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 48: 1565-1575.
20. AATTOUR, N., M. BOURAS, D. TOME, et al. 2002. Oral ingestion of lactic-acid bacteria by rats increases lymphocyte proliferation and interferon-gamma production. Br. J. Nutr. 87: 367-373.
21. HALPERN, G. M., W.J. VAN DE, A.M. DELABROISE, et al. 1991. Comparative uptake of calcium from milk and a calcium-rich mineral water in lactose intolerant adults: implications for treatment of osteoporosis. Am. J. Prev. Med. 7: 379-383.
22. HELWIG, U., K.M. LAMMERS, F. RIZZELLO, et al. 2006. Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J. Gastroenterol. 12: 5978-5986.